Display options
Cite
Hall LT, Titz B, Robins HI, et al. PET/CT imaging of the diapeutic alkylphosphocholine analog . Am J Nucl Med Mol Imaging. 2017;7(4):157-166
Hall, L. T., Titz, B., Robins, H. I., Bednarz, B. P., Perlman, S. B., Weichert, J. P., & Kuo, J. S. (2017). PET/CT imaging of the diapeutic alkylphosphocholine analog . American journal of nuclear medicine and molecular imaging, 7(4), 157-166.
Hall, Lance T, et al. "PET/CT imaging of the diapeutic alkylphosphocholine analog ." American journal of nuclear medicine and molecular imaging vol. 7,4 (2017): 157-166.
Hall LT, Titz B, Robins HI, Bednarz BP, Perlman SB, Weichert JP, Kuo JS. PET/CT imaging of the diapeutic alkylphosphocholine analog . Am J Nucl Med Mol Imaging. 2017 Sep 01;7(4):157-166. eCollection 2017. PMID: 28913154; PMCID: PMC5596318.
Copy Download .nbib Format: NLM
Share it on

Am J Nucl Med Mol Imaging. 2017 Sep 01;7(4):157-166. eCollection 2017.

PET/CT imaging of the diapeutic alkylphosphocholine analog .

American journal of nuclear medicine and molecular imaging

Lance T Hall, Benjamin Titz, H Ian Robins, Bryan P Bednarz, Scott B Perlman, Jamey P Weichert, John S Kuo

Affiliations

  1. Department of Radiology, University of WisconsinMadison, WI, USA.
  2. Department of Carbone Cancer Center, University of WisconsinMadison, WI, USA.
  3. Cellectar Biosciences, IncMadison, WI, USA.
  4. Department of Human Oncology, University of WisconsinMadison, WI, USA.
  5. Department of Neurology, University of WisconsinMadison, WI, USA.
  6. Department of Medicine, University of WisconsinMadison, WI, USA.
  7. Department of Medical Physics, University of WisconsinMadison, WI, USA.
  8. Department of Neurological Surgery, University of WisconsinMadison, WI, USA.

PMID: 28913154 PMCID: PMC5596318

Abstract

CLR1404 is a cancer-selective alkyl phosphocholine (APC) analog that can be radiolabeled with

Keywords: CLR1404; PET; alkyl phosphocholine analog; brain tumor; high grade brain tumor; low grade brain tumor; molecular imaging

Conflict of interest statement

None.

References

  1. Sci Transl Med. 2014 Jun 11;6(240):240ra75 - PubMed
  2. Q J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90 - PubMed
  3. Hell J Nucl Med. 2015 May-Aug;18(2):152-6 - PubMed
  4. J Neurosurg Pediatr. 2010 May;5(5):486-99 - PubMed
  5. J Nucl Med. 2014 Apr;55(4):540-5 - PubMed
  6. Neurosurgery. 2009 Mar;64(3):471-81; discussion 481 - PubMed
  7. J Nucl Med. 2014 Oct;55(10 ):1611-6 - PubMed
  8. Mol Pharm. 2016 Sep 6;13(9):3341-9 - PubMed
  9. Neurosurgery. 2015 Feb;76(2):115-23; discussion 123-4 - PubMed
  10. Neuro Oncol. 2016 Sep;18(9):1199-208 - PubMed
  11. PET Clin. 2015 Jul;10 (3):423-30 - PubMed
  12. Methods Mol Biol. 2011;727:291-315 - PubMed
  13. J Med Chem. 2006 Apr 6;49(7):2155-65 - PubMed
  14. Acta Radiol. 2016 Mar;57(3):325-32 - PubMed
  15. Expert Rev Neurother. 2013 Apr;13(4):389-403 - PubMed
  16. Nucl Med Commun. 2015 Jul;36(7):695-701 - PubMed
  17. J Nucl Med. 2014 Jan;55(1):30-6 - PubMed
  18. CNS Oncol. 2016 Oct;5(4):223-31 - PubMed
  19. J Nucl Med. 2012 Jan;53(1):29-36 - PubMed

Publication Types

Grant support